WhaleCreep

Which hedge funds own GALT? GALECTIN THERAPEUTICS INC, Q2 2026 13F holders

7 tracked hedge funds disclosed a position in GALT (GALECTIN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $7.4m in total. The largest holder by portfolio weight is Gsa Capital Partners LLP at 0.0% of its book. 8 exited: 683 Capital Management, LLC, Diametric Capital, LP, Catalyst Funds Management Pty Ltd.

7
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
0
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
8
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$0
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$1.3m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$7.4m
Combined value
Sum of the holders' reported positions in the security.
0.6%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.

Holders, Q2 2026

7 rows
Gsa Capital Partners LLP Hedge fund0.04%$597k128,664+80%added
Marshall Wace, LLP Hedge fund0.0%$3.9m831,010−32%reduced
Horizon Kinetics (Murray Stahl) Long-only investor0.0%$218k46,968−4.6%reduced
Two Sigma Investments, LP Hedge fund0.0%$1.5m318,245−32%reduced
Citadel Advisors LLC Hedge fund0.0%$922k198,701−32%reduced
Renaissance Technologies LLC Hedge fund0.0%$201k43,343−71%reduced
Millennium Management LLC Hedge fund0.0%$166k35,863−96%reduced